It is worth noting that arsenic trioxide is an effective therapeutic for promyelocytic leukemia with t(15;17) translocation that produces the fusion protein promyelocytic leukemia (PML)‐retinoic acid receptor‐α (RARα). The gene discussed is PML; the disease is acute promyelocytic leukemia.